Yahoo Web Search

Search results

1. • 

     Can You Take Creatine and Caffeine Together?

     Health via Yahoo News· 7 hours ago

     It benefits both athletes and non-athlete exercisers. It may also benefit several health conditions. Research suggests that creatine may: Enhance...

2. • Coeptis Therapeutics (COEP) versus The Competition Head to Head Comparison

     ETF DAILY NEWS· 6 days ago

     Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 286 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors ...

3. • 

     Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson's disease

     Medical Xpress· 3 days ago

     Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without...

4. • 

     Brain Injury More Severe From Falls at U.S.-Mexico Border Wall

     MedPage Today· 7 days ago

     People with border wall falls were less likely to receive follow-up care

5. • ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Post Q2 2024 Earnings of $0.17 Per Share, Leerink...

     ETF DAILY NEWS· 4 days ago

     ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Research analysts at Leerink Partnrs decreased their Q2 2024 EPS estimates for shares of ACADIA Pharmaceuticals in ...

6. • Acorda Therapeutics (NASDAQ:ACOR) Coverage Initiated by Analysts at StockNews.com

     ETF DAILY NEWS· 5 days ago

     Equities research analysts at StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Get Free Report) in a report issued on Friday. The firm set a “buy ...

7. • Brokerages Set Alector, Inc. (NASDAQ:ALEC) PT at $14.50

     ETF DAILY NEWS· 15 hours ago

     (NASDAQ:ALEC – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. One

8. • ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Short Interest Up 5.4% in March

     ETF DAILY NEWS· 12 hours ago

     As of March 31st, there was short interest totalling 11,200,000 shares, an increase of 5.4% from the March 15th total of 10,630,000 shares. In related news, CEO Stephen Davis ...

9. • DekaBank Deutsche Girozentrale Buys 242,924 Shares of Enhabit, Inc. (NYSE:EHAB)

     ETF DAILY NEWS· 2 days ago

     The institutional investor owned 244,924 shares of the company’s stock after acquiring an additional 242,924 shares during the period. DekaBank Deutsche Girozentrale owned approximately < ...

10. • Minerva Neurosciences (NASDAQ:NERV) Shares Pass Below 200 Day Moving Average of $5.76

      ETF DAILY NEWS· 5 days ago

      Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.76 and traded ...